They have the same active ingredients—but experts say there are some key factors that set these medications apart at the pharmacy counter. One of the biggest is cost. An employee inspects medications ...

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...

A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...

Margo Martindale and Natalie Portman are among the voice cast for this Phil Johnston-directed version of the beloved author’s ickiest book. By Richard Lawson While some young Roald Dahl fans, like me, ...

A division bench of Delhi high court Thursday rejected the appeal of pharma giant, Roche, seeking an injunction against Indian pharma company Natco Pharma launching a generic version of Risdiplam, the ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Gilead Sciences, Inc. (NASDAQ:GILD) announced Monday that it has entered into settlement agreements to resolve patent litigation with generic pharmaceutical companies Lupin Ltd., Cipla Ltd., and ...

Against a backdrop of tariff updates and a drug pricing deal from the Trump administration, the FDA charted a pair of moves this week in its push to make drug manufacturing more attractive in the U.S.

Dr. Reddy's Laboratories won't market a generic version of Esperion Therapeutics' cholesterol drugs after a reaching a settlement. Esperion Therapeutics, a pharmaceutical company, said Friday that it ...

The Trump administration’s approval of generic abortion pills has prompted an immediate and strong condemnation from conservative lawmakers who question the safety of the pill, given the timeline of ...

President Donald Trump announced on Thursday (September 25, 2025) a 100% tariff on branded and patented pharmaceutical imports, effective October 1, 2025, unless companies establish manufacturing ...